Chrna5tm1.1Itl
Targeted Allele Detail
|
|
| Symbol: |
Chrna5tm1.1Itl |
| Name: |
cholinergic receptor, nicotinic, alpha polypeptide 5; targeted mutation 1.1, inGenious Targeting Laboratory |
| MGI ID: |
MGI:5767316 |
| Synonyms: |
alpha5DN |
| Gene: |
Chrna5 Location: Chr9:54888164-54915063 bp, + strand Genetic Position: Chr9, 29.84 cM
|
| Alliance: |
Chrna5tm1.1Itl page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:225451
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
C57BL/6
|
|
| Allele Type: |
|
Targeted (Dominant negative) |
| Mutations: |
|
Insertion, Nucleotide substitutions
|
| |
|
Mutation details: A G to A point mutation results in the amino acid substitution of asparagine for aspartic acid at position 397 (D397N). This mutation results in a dominant negative. The neomycin resistance cassette was removed. This nonsynonymous engineered SNP is equivalent to the human SNP rs16969968
(J:225451)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Chrna5 Mutation: |
40 strains or lines available
|
|
| Original: |
J:225451 Sciaccaluga M, et al., Crucial role of nicotinic alpha5 subunit variants for Ca2+ fluxes in ventral midbrain neurons. FASEB J. 2015 Aug;29(8):3389-98 |
| All: |
2 reference(s) |
|